Alpla and Inden pharma form joint venture

ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma

Shilpa Medicare gets 2 minor observations from USFDA for Unit VII, Analytical Services Division

The company will be submitting the responses to US FDA observations within stipulated timeline

Keytruda + chemotherapy improved overall survival versus chemotherapy alone as for advanced malignant pleural mesothelioma

For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma

Marksans Pharma announces USFDA approval for Famotidine Tablets

Marksans' OTC Famotidine Tablets USP are acid reducers

USFDA completes inspection of Lupin’s Vizag facility

The inspection concluded with no observations

Build a sustainable healthcare and lifesciences industry, say Experts

Time to combine innovation, access and technology to deliver positive patient outcomes

IIT Kanpur and Reliance Life Sciences join forces to revolutionize gene therapy for hereditary eye diseases

IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases

Zydus receives final approval from the USFDA for Erythromycin Tablets

Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body

Alembic receives USFDA tentative approval for Brexpiprazole Tablets

Clariant launches Plantasens Pro LM

Plantasens Pro LM is 100% natural, readily biodegradable, COSMOS and Natrue certified